Dupixent (dupilumab) is a widely used biologic therapy for inflammatory conditions like moderate-to-severe atopic dermatitis, asthma, chronic rhinosinusitis with nasal polyps, eosinophilic esophagitis, and prurigo nodularis. Patients can self-inject the medicine at home using a pre-filled pen or a pre-filled syringe.
This article explores the differences between the Dupixent pen vs. syringe, what research says about injection pain, and what you can do to reduce discomfort.
Available dosage forms and strengths of Dupixent
Dupixent comes in single-dose, ready-to-use devices:
|
Device |
Strengths available |
Approved ages |
|
Pre-filled pen |
200 mg/1.14 mL, 300 mg/2 mL |
2 years and older |
|
Pre-filled syringe |
200 mg/1.14 mL, 300 mg/2 mL |
6 months and older |
Both devices contain either 300 mg of dupilumab in 2 mL (150 mg/mL) or 200 mg in 1.14 mL (175 mg/mL). These are the most common strengths used for adolescents and adults.
The pre-filled pen is approved for adults and children aged 2 years and older, while the pre-filled syringe may be used in adults and children starting at 6 months of age. This broader age range for the syringe means caregivers can administer the medication to infants and young children under medical supervision.
How to inject Dupixent using the pre-filled pen
The pen is an autoinjector. The needle is concealed, which can be less intimidating for people who are afraid of needles. However, you cannot adjust how fast the medication enters the skin.
How to inject Dupixent using the pre-filled syringe
The syringe’s needle is visible, and some people dislike seeing it. On the other hand, many users appreciate being able to control the pace of the injection, which may lessen discomfort.
Is the Dupixent syringe less painful than the pen?

Several studies have tried to determine which device causes more discomfort. A 2023 open-label study in Japan enrolled 331 people who self-administered dupilumab using either a pen or a syringe. Participants rated injection pain on a visual analogue scale (VAS).
The median pain score for the pen was 5.1 out of 10, while the syringe scored 3.4. The difference was statistically significant, and researchers noted that the pen’s fast injection speed may contribute to the higher pain score. Despite the higher pain, most patients found the pen easier to use and were satisfied with it.
A SingleCare article interviewed allergist Dr. Purvi Parikh, who treats patients on Dupixent. Dr. Parikh noted that many people find the syringe less painful, adding that some patients request a switch from the pen because they feel a noticeable difference.
On Featured.com, clinicians answered questions about device differences. One clinical advisor explained that the pen delivers the medication at a fixed speed, leading some patients to feel a brief, more intense sting. By contrast, the syringe allows users to inject the medicine slowly, sometimes reducing discomfort.
In an Asthma.net forum thread, one user wrote that the auto-injector was quite painful. Other participants did not have clear tricks to reduce pain but advised consulting healthcare providers.
Reddit posts and other community forums often mention that the pen’s spring-loaded mechanism can produce a sharp burn, whereas users who inject slowly with the syringe report only mild discomfort.
Remember that individual experiences vary and that anecdotal reports should not replace professional advice.
Factors that influence injection discomfort
Injection pain is not determined solely by the device. Several factors can affect how a shot feels:
-
- Temperature of the medication – Injecting a cold solution can cause a burning sensation. Dupixent manufacturer advises letting the pen or syringe warm to room temperature (45 minutes for the 300 mg devices and 30 minutes for 200 mg devices).
-
- Injection technique – Injecting too quickly can create a burning sensation. The syringe allows you to push the plunger slowly. For the pen, you can press firmly and count to five while the device injects. After the injection, lightly pressing a cotton ball or gauze without rubbing can reduce irritation.
-
- Injection site – Approved sites include the thigh or stomach for self-injection and the upper arm when someone else administers the shot. Many users report that the stomach is less sensitive than the thigh. Avoid injecting into bruised, scarred, or sensitive skin.
-
- Volume of medication – A general study on injection speed and pain found that injection volume influenced pain more than speed. Larger volumes, ranging from 1.2 mL to 2.25 mL, were slightly more painful. Considering these findings, the 300 mg dose (2 mL) may feel more uncomfortable than the 200 mg (1.14 mL) dose, regardless of the device.
-
- Personal pain threshold and anxiety – Some people are more sensitive to injection pain, and anxiety can make the experience feel worse. Relaxation techniques or distraction, such as listening to music or deep breathing, may help.
Tips to reduce injection discomfort
Following proper technique and preparation can make injections more comfortable. Medical experts and patient resources recommend the following steps:
Pros and cons of Dupixent pen vs. syringe
Understanding the pros and cons of each option can help you choose the one that feels more comfortable and easier to use.
Convenience and ease of use
The pen simplifies injection because the device automatically delivers the dose. It may be appealing for people with limited dexterity or a fear of needles. Many patients feel more confident using a pen because there is less room for error. The automatic mechanism also ensures the full dose is delivered without having to watch the plunger.
The syringe requires more steps, which can be intimidating, especially for first-time users. However, it allows users to adjust the speed of injection. Some patients appreciate this control and report less pain as a result.
Pain perception
Clinical data and expert opinions indicate that the pen may produce a sharper, more intense sensation due to its fixed injection speed. The syringe allows a slower, steadier injection, which many patients perceive as less painful. Nonetheless, pain is subjective. Some people find the pen tolerable and prefer its simplicity.
Needle visibility
The pen hides the needle completely until after the shot. This can reduce anxiety for those uncomfortable with seeing needles. The syringe has a visible needle, which may be off-putting for some. However, others appreciate seeing where the needle goes and how far to insert it.
Age considerations
The prefilled syringe is approved for younger children, including infants, because it allows caregivers to control needle insertion and injection speed more precisely. The pen is approved only for older children and adults, as it requires pressing and holding the device firmly against the skin, which is less suitable for small body areas in younger patients.
Storage and handling
Both devices must be stored in the refrigerator at 36-46 °F (2-8 °C) in their original carton away from light. Dupixent can be kept at room temperature (up to 77 °F/25 °C) for up to 14 days, but must be used within that time or discarded. The medication should never be heated or frozen.
Bottom line
Both Dupixent devices deliver the same medication, yet they differ in ease of use, dosing flexibility, and injection experience. Evidence from clinical studies, expert commentary, and patient stories suggests that the syringe may cause less injection pain because you control the speed of injection. The pen, however, is convenient and hides the needle, which many people appreciate.
Injection pain is manageable. Letting the device warm up, choosing the right site, injecting slowly, and rotating sites can make the experience more comfortable. Remember that everyone’s experience is unique. Talk with your healthcare provider about your preferences, ask for a demonstration, and do not hesitate to switch devices if you find one method too uncomfortable.
Dupixent is meant to improve your quality of life, so the delivery method should support that goal.
Frequently Asked Questions
Related Articles
Sources
Hosoya, K., Komachi, T., Masaki, K., Suzaki, I., Saeki, H., Kanda, N., Nozaki, M., Kamide, Y., Matsuwaki, Y., Kobayashi, Y., Ogino, E., Osada, S., Usukura, N., Kurumagawa, T., Ninomia, J., Asako, M., Nakamoto, K., Yokoi, H., Ohyama, M., . . . Okubo, K. (2023). Barrier Factors of Adherence to Dupilumab Self-Injection for Severe Allergic Disease: A Non-Interventional Open-Label Study. Patient Preference and Adherence, Volume 17, 861–872. https://doi.org/10.2147/ppa.s389865
Surles, T., & SingleCare. (2026, January 28). Dupixent pen vs. syringe: How to choose the right option. The Checkup. https://www.singlecare.com/blog/dupixent-pen-vs-syringe/
Zijlstra, E., Jahnke, J., Fischer, A., Kapitza, C., & Forst, T. (2017). Impact of injection speed, volume, and site on pain sensation. Journal of Diabetes Science and Technology, 12(1), 163–168. https://doi.org/10.1177/1932296817735121
Dupixent™ (n.d.). https://www.dupixent.com/taking-dupixent/injection-support-center





